Lorenz is working as Entrepreneur-in-Residence (EiR) for Hevolution in Boston/MA with a focus on finding and reviewing investment opportunities towards new treatments for anti-aging, longevity and healthspan extension. In addition, he is running as a Managing Director the company Mayr BioMedTech Consulting in Basel, Switzerland. The company provides consulting services not only to BioPharma, Biotechnology and MedTech companies but also to governmental and academic institutions. Lorenz is a highly respected biopharmaceutical executive with extensive experience over the last 30 years in drug discovery, technology and innovation, business growth and financing strategy. He has previously worked as a Chairman, Non-Executive Director, Chief Executive Officer, Chief Technology Officer, and Entrepreneur-in-Residence in the Biotech, Medtech, Pharma and Venture Capital industry across Europe and the US. Lorenz currently serves on the Board of Directors at Fundamental Pharma (Heidelberg, Germany), Mogrify (Cambridge, UK), InCephalo (Basel, Switzerland), and serves on the Scientific Advisory Board of Molecular Discovery Catapult (Alderley Park, UK), Fraunhofer IGB (Stuttgart, Germany), Fraunhofer IZI (Leipzig, Germany), SaxoCell (Leipzig), The Francis Crick Institute (London, UK), LenioBio (Düsseldorf, Germany), SensibleBio (Oxford, UK), Hemotune (Zurich, Switzerland), TQ Therapeutics (Munich, Germany), GeneFab (San Francisco, CA) and works as Senior Healthcare Advisor to EQT Investments (Stockholm/Sweden).